Consistent engagement with current medical literature enables clinicians to apply the latest evidence-based treatment and integrate research into clinical practice. This approach enhances patient outcomes by facilitating more effective and individualized care.

Today, we’re showcasing some of the latest psychiatry-related articles published recently across medical journals. The articles in today’s rundown are focused on or related to anxiety disorders and mood disorders.

Anxiety Disorder Articles

Quantitative Electroencephalography Analysis in Panic Disorder: Exploring the Neurophysiological Significance of High Beta Activity

  • Psychiatry Investigation, February 2026
  • Description: This study aimed to investigate the neurophysiological characteristics of panic disorder (PD) by analyzing quantitative electroencephalography (QEEG) data, with a particular focus on high beta activity.
  • Summary
  • Full Text

Dose–Concentration Relationship and Clinical Outcomes of Duloxetine in Generalized Anxiety Disorder

  • Journal of Clinical Medicine, February 2026
  • Description: This study aimed to investigate plasma duloxetine concentrations, factors influencing these concentrations, and the relationship between plasma levels and clinical response in patients diagnosed with generalized anxiety disorder who were treated with duloxetine.
  • Summary
  • Full Text

Instructed Increase in Fear Activation During Exposure Exercises Does Not Enhance Treatment Effects of Cognitive Behavioral Therapy for Panic Disorder and Agoraphobia

  • Behaviour Research and Therapy, February 2026
  • Description: The efficacy of exposure-based cognitive behavioral therapy (eCBT) for panic disorder and agoraphobia (PD/AG) is well established, but the mechanisms of action are still under debate. Here [the researchers] investigated whether increased fear activation (by provoking additional bodily symptoms using interoceptive challenges) during exposure to agoraphobic situations would improve therapy outcome.  
  • Summary
  • Full Text

Multi-ancestry Epigenome Wide Association Study of Generalized Anxiety Disorder

  • MedRxiv, January 2026
  • Description: Epigenetic studies face persistent challenges related to small sample sizes, particularly when using epigenome-wide array technologies. Presumably it is this limitation that has hindered the discovery of replicable and robust findings, much like the early struggles of genome-wide association studies. To address this gap, we conducted one of the largest epigenetic investigations of generalized anxiety disorder using 43,504 participant’s data from the Million Veteran Program.
  • Summary
  • Full Text
Mood Disorder Articles

A Systematic Exploration of Digital Biomarkers for the Detection of Depressive Episodes in Biopolar Disorder

  • NPJ Mental Health Research, February 2026
  • Description: This longitudinal study used explainable machine learning to analyze multivariate, densely sampled data from 133 bipolar disorder participants over a median of 251 days, identifying robust digital biomarkers defining depressive episodes.
  • Summary
  • Full Text

Differentiation Between Psychotic and Non-Psychotic Major Depression by the Tabular Prior-Data Fitted Network

  • Journal of Affective Disorders, February 2026
  • Description: Misdiagnosing psychotic major depression as non-psychotic major depression can lead to poor treatment outcomes. This study aims to develop and validate a machine learning-based model using electronic medical record data and the Tabular Prior-data Fitted Network model to distinguish between psychotic major depression and non-psychotic major depression.
  • Summary
  • Full Text

Aberrant Brain Activity During Sad-Happy Emotional Switching in Adolescents with Bipolar Disorder: A Functional MRI Study

  • Behavioural Brain Research, February 2026
  • Description: Adolescents with bipolar disorder (BD) experience rapid mood fluctuations and cognitive disturbance. However, the underlying neural mechanism for sad-happy emotional switching remains poorly understood in adolescents with BD.
  • Summary
  • Full Text

Does Mental Health Coaching Improve Efficacy of Transcranial Magnetic Stimulation for Major Depression? A Pilot Randomized Controlled Trial and Benchmarking Study

  • Journal of Affective Disorders, February 2026
  • Description: Major depressive disorder is common and burdensome. Repetitive Transcranial Magnetic Stimulation is recommended for individuals who do not respond to first-line treatments. Coach-supported digital mental health programs are scalable strategies for delivering therapeutic content. This randomized controlled trial tested whether digital mental health programs bolster repetitive transcranial magnetic stimulation for major depressive disorder .
  • Summary
  • Full Text

Look forward to more journal-focused topics in the coming weeks. 

Sign up for alerts and stay informed on the latest published articles and guidelines.

Copyright © 2026 Guideline Central, all rights reserved.